Physician profile
Lisa Abaid
NPI 1295943132
$13,268.25
in general payments reported to CMS, 2019-2025
9 companies · $4,625 in 2025
The $4,625 reported for 2025 was more than what 86% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $14.94 · 2021: $40.98 · 2023: $4,028 · 2024: $4,400 · 2025: $4,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,700 · Education: $4,000 · Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,700.00 |
| Education | $4,000.00 |
| Food and Beverage | $352.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $8,736.69 | 2024-2025 | Shingrix, Jemperli |
| Intuitive Surgical, INC. | $4,295.45 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $113.01 | 2025 | Tisseel |
| Astrazeneca Pharmaceuticals LP | $65.70 | 2019-2020 | |
| Biosense Webster, INC. | $21.38 | 2021 | |
| Merck Sharp & Dohme LLC | $19.60 | 2021 | |
| Medtronic, INC. | $15.70 | 2024 | Abre |
| Clovis Oncology, INC. | $0.72 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Abaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.